![]() |
市場調查報告書
商品編碼
1819999
2025-2033 年家庭輸液治療市場報告(按產品、應用和地區)Home Infusion Therapy Market Report by Product, Application, and Region 2025-2033 |
2024年,全球家庭輸液治療市場規模達454億美元。展望未來, IMARC Group預計到2033年,市場規模將達到708億美元,2025-2033年期間的複合年成長率(CAGR)為5.1%。老年人口的成長以及人們對家庭醫療保健的日益偏好,正在推動市場的發展。
先進輸液技術的採用日益增多
技術進步正在透過引入智慧輸液幫浦和安全軟體來增強家庭輸液治療,從而提高精準度、安全性和效率。這些創新有助於減少用藥錯誤,提供更完善的監測,並與數位系統無縫整合,從而簡化患者的家庭護理並減輕護理人員的負擔。例如,2024年4月,百特的Novum IQ大容量輸液幫浦和Dose IQ安全軟體獲得美國FDA批准,透過提供整合式智慧型幫浦解決方案來增強居家輸液治療。這項進展提高了患者的安全性和效率,解決了臨床醫生的工作量挑戰,並推進了互聯醫療。
專業輸液服務需求不斷成長
隨著越來越多的患者需要複雜的慢性病治療,對專業輸液服務的需求也日益成長。此外,這些服務提供居家客製化治療,從而減少患者就診需求。此外,這種個人化方法有助於有效管理長期疾病,同時提高患者舒適度和治療效果。例如,Dynamic Access 於 2024 年 2 月推出了 Dynamic Infusion,這是一家專業的家庭輸液護理服務提供商,為自體免疫疾病和多發性硬化症等慢性病患者提供服務。此外,他們還與 35 多家專業藥局合作,每年在九個州提供超過 10,000 次上門服務,提升病患照護水準。
數位健康工具的整合
數位工具與居家輸液治療的整合,使得醫療服務提供者和患者之間能夠更好地監測患者病情,並實現即時資料共享。此外,這些系統還能提供對治療進展的洞察,從而增強遠距護理管理,提高依從性,方便調整治療計劃,同時最大限度地減少面對面諮詢的需求。例如,2024年5月,穆格公司專為居家輸液治療設計的CURLIN 8000行動輸液系統獲得美國FDA核准。該系統提供精準的多療法輸液和直覺的用戶介面,並與CURLIN RxManager整合,增強了家庭護理藥劑師和患者的安全性和可控性。
The global home infusion therapy market size reached USD 45.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 70.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.1% during 2025-2033. The growing elderly population, along with the increasing preference for home healthcare, is propelling the market.
Increasing Adoption of Advanced Infusion Technology
Technological advancements are enhancing home infusion therapy by introducing smart infusion pumps and safety software that improve precision, safety, and efficiency. In contrast, these innovations help to reduce medication errors, offer better monitoring, and provide seamless integration with digital systems, thereby streamlining home-based care for patients and reducing the burden on caregivers. For instance, in April 2024, Baxter received U.S. FDA clearance for its Novum IQ large volume infusion pump and Dose IQ Safety Software, thereby enhancing home infusion therapy by offering integrated smart pump solutions. This development boosts patient safety and efficiency, addressing clinician workload challenges and advancing connected care.
Growing Demand for Specialized Infusion Services
The need for specialized infusion services has grown as more patients require complex treatments for chronic conditions. In addition, these services provide tailored therapies delivered in a home setting, thereby reducing the need for hospital visits. Furthermore, this personalized approach helps to manage long-term illnesses effectively while improving patient comfort and treatment outcomes. For instance, in February 2024, Dynamic Access launched dynamic infusion, a specialty home infusion nursing provider, which is serving patients with chronic conditions like autoimmune disorders and multiple sclerosis. Also, they partnered with 35+ specialty pharmacies, offering over 10,000 home visits annually across nine states, enhancing patient care.
Integration of Digital Health Tools
The integration of digital tools in home infusion therapy is enabling better patient monitoring and real-time data sharing between healthcare providers and patients. Moreover, these systems enhance remote care management by offering insights into therapy progress, thereby improving adherence and facilitating adjustments to treatment plans while minimizing the need for in-person consultations. For instance, in May 2024, Moog received U.S. FDA clearance for the CURLIN 8000 ambulatory infusion system, designed specifically for home infusion therapy. This system offers precise multi-therapy infusions and intuitive user interfaces and integrates with CURLIN RxManager, enhancing safety and control for home care pharmacists and patients.
Infusion pumps currently hold the largest home infusion therapy market demand
Infusion pumps exhibit a clear dominance in the market due to their precision in medication delivery, as they offer defined medication delivery and enhancing patient care. For example, Baxter launched its advanced Spectrum IQ pump, thereby improving patient safety and remote monitoring capabilities for home-based care.
Anti-infectives currently hold the largest home infusion therapy market statistics
Anti-infectives lead the market due to their increased use in treating severe infections, such as pneumonia, with intravenous antibiotics. For instance, Smiths Medical's CADD infusion system facilitates precise delivery and supports increased adoption.
North America currently dominates the infusion therapy market revenue
The home infusion therapy market outlook has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
As per the home infusion therapy market overview, North America dominates the market, which is driven by advanced healthcare infrastructure and increasing demand for home-based treatments. Moreover, the region benefits from a growing elderly population and rising chronic disease cases, prompting more home infusion therapies. For example, CVS Health expanded its home infusion services, thereby enhancing access to these treatments across the U.S. Furthermore, high demand for at-home care, alongside supportive reimbursement policies and technological advancements, further strengthens the region's dominance in this market.